$150 million new vaccines plant commissioned in Russia

Russia’s largest plant for the production of vaccines and one of the biggest in Eastern Europe was recently commissioned in the Yaltunovo area of the Ryazan region by Fort Group, a leading Russian investment group.

The investment in the project amounted to 4.8 billion roubles ($150 million), the majority of which were provided by Vnesheconombank, one of Russia’s largest banks.

The new complex will have the capacity to produce up to 40 million doses of seasonal influenza vaccine, 120 million doses of pandemic influenza vaccine, 20 million doses of other viral vaccines, 100 million doses of recombinant proteins and up to 50 million of special forms of drugs.